Refuseniks Celebrate New Triumphs, Face New Hurdles

Many scientists once denied emigration have now left the USSR, but others are still unable to obtain exit visas. Yuri Magarshack is doing science again. Today, he is an assistant researcher in the chemistry department at New York University. Yet for an 11-year period that ended last spring, the theoretical physicist was struggling to endure life as a refusenik - a Soviet citizen, usually Jewish, who is denied permission to emigrate. Dismissed from his job as head of a laboratory in Leningrad's

Written byBarbara Spector
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share


Many scientists once denied emigration have now left the USSR, but others are still unable to obtain exit visas.
Yuri Magarshack is doing science again. Today, he is an assistant researcher in the chemistry department at New York University. Yet for an 11-year period that ended last spring, the theoretical physicist was struggling to endure life as a refusenik - a Soviet citizen, usually Jewish, who is denied permission to emigrate. Dismissed from his job as head of a laboratory in Leningrad's Polytechnical Institute, he had to find work as a lifeguard to support himself. In the USSR, "many of my colleagues were afraid to talk to me," he recalls. But in the United States, he marvels, "it's possible to work, not thinking about anything else."

The happy ending to Magar-shack's saga is by no means unique. Within the last three years, the trickle of refusenik scientists being permitted to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies